Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

605

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

Daclatasvir

Film-coated tablet, oral, 60 mg, once daily, 24 weeks

DRUG

Telaprevir

Film-coated tablet, oral, 750 mg, 3 times daily

DRUG

Peginterferon alfa-2a

Solution for injection, subcutaneous injection, 180 μg, weekly

DRUG

Ribavirin

Film-coated tablet, oral, in a body weight stratified dose range of 1000-1200 mg per day

Trial Locations (91)

1090

Local Institution, Vienna

1160

Local Institution, Vienna

1629

Local Institution, Prov. Buenos Aires

2000

Local Institution, Prov de Santa Fe

2050

Local Institution, Camperdown

2145

Local Institution, Westmead Nsw

2650

Local Institution, Hvidovre

2750

Local Institution, Penrith

3181

Local Institution, Prahran

4010

Local Institution, Linz

4120

Local Institution, Greenslopes Qld

5000

Local Institution, Adelaide

Local Institution, Odense

8091

Local Institution, Zurich

10021

Weill Cornell Medical College, New York

10100

Local Institution, Torino

10969

Local Institution, Berlin

13110

Local Institution, Safed

13353

Local Institution, Berlin

16100

Local Institution, Nazareth

19141

Albert Einstein Medical Center, Philadelphia

20246

Local Institution, Hamburg

21093

Johns Hopkins University, Lutherville

24127

Local Institution, Bergamo

25000

Local Institution, Besançon

27710

Duke University Medical Center, Durham

28203

Carolinas Medical Center, Charlotte

28922

Local Institution, Alcorcón

30060

Gastrointestinal Specialists Of Georgia, Marietta

30312

Atlanta Medical Center, Atlanta

30625

Local Institution, Hanover

31096

Local Institution, Haifa

32803

Orlando Immunology Center, Orlando

33600

Local Institution, Pessac

35294

The Kirklin Clinic, Birmingham

38043

Local Institution, Grenoble

45122

Local Institution, Essen

46010

Local Institution, Valencia

50134

Local Institution, Florence

50937

Local Institution, Cologne

55114

Minnesota Gastroenterology, P.A., Saint Paul

56124

Local Institution, Cisanello (pisa)

59037

Local Institution, Lille

60590

Local Institution, Frankfurt

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63104

Saint Louis University Gastroenterology & Hepatology, St Louis

64239

Local Institution, Tel Aviv

67090

Local Institution, Strasbourg

75571

Local Institution, Paris

75651

Local Institution, Paris

77030

Baylor College Of Medicine, Houston

Research Specialists Of Texas, Houston

78215

Alamo Medical Research, San Antonio

78234

Brooke Army Medical Center, Fort Sam Houston

79106

Local Institution, Freiburg im Breisgau

80131

Local Institution, Napoli

85054

Mayo Clinic Arizona, Phoenix

90822

Va Long Beach Healthcare System, Long Beach

92123

Medical Associates Research Group, San Diego

93143

Local Institution, Bondy

109240

Local Institution, Moscow

119991

Local Institution, Moscow

121170

Local Institution, Moscow

06520-8019

Yale University School Of Medicine, New Haven

21201-1595

University Of Maryland, Baltimore

27599-7584

University Of North Carolina At Chapel Hill School Of Med, Chapel Hill

02905

University Gastroenterology, Providence

02906

The Miriam Hospital, Providence

C1121ABE

Local Institution, Ciudad de Buenos Aires

C1181ACH

Local Institution, Ciudad de Buenos Aires

3065 VIC

Local Institution, Fitzroy

04023-062

Local Institution, São Paulo

T2N 4Z6

Local Institution, Calgary

T6G 2B7

Local Institution, Edmonton

V6Z 2K5

Local Institution, Vancouver

R3E 3P4

Local Institution, Winnipeg

K1H 8L6

Local Institution, Ottawa

M5G 2N2

Local Institution, Toronto

15-540

Local Institution, Bialystok

41-500

Local Institution, Chorzów

25-317

Local Institution, Kielce

41-400

Local Institution, Mysłowice

47-400

Local Institution, Racibórz

50-220

Local Institution, Wroclaw

08003

Local Institution, Barcelona

08036

Local Institution, Barcelona

SE5 9RS

Local Institution, London

EH4 2XU

Local Institution, Edinburgh

G12 0YN

Local Institution, Glasgow

B15 2TH

Local Institution, Birmingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01492426 - Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter